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New function for an old master
T
he master regulator of muscle differentiation, MyoD, 
functions early in myogenesis to help stem cells prolifer-
MyoD is a transcription factor that activates muscle-
specifi  c genes as myoblast precursors differentiate and fuse to 
form mature muscle fi  bers. But MyoD is also expressed at an 
earlier stage of myogenesis when quiescent stem cells rapidly 
expand in number to generate the myoblasts needed to repair 
tissue damage. The transcription factor’s function in this pro-
liferative phase is unknown.
Zhang et al. found that MyoD bound to the promoter of 
CDC6, a gene that initiates DNA replication, suggesting that MyoD 
might activate Cdc6 expression in muscle stem cells to promote 
their reentry into the cell cycle and rapid proliferation. Indeed, 
Cdc6 was expressed shortly after MyoD in stimulated muscle 
progenitors, and knocking down MyoD reduced Cdc6 production 
and slowed cells’ entry into S phase. MyoD works in conjunction 
with transcription factors from the E2F family. E2F3a activated 
the CDC6 promoter with MyoD, but was replaced by the repres-
sive family member E2F4 as myoblasts began to differentiate.
Senior author Nikki Harter now wants to investigate how 
the transcription factors cooperate to control Cdc6 expression—
initial results suggest that MyoD recruits E2F3a to the promoter 
region. The researchers also propose that a related protein, Myf5, 
might control Cdc6 transcription in MyoD’s absence, acting as 
a backup mechanism to ensure that muscle stem cells expand to 
repair tissue damage.
Zhang, K., et al. 2010. J. Cell Biol. doi:10.1083/jcb.200904144.
Segregating out UbcH10’s role in tumorigenesis
A 
ubiquitin-conjugating 
enzyme that regulates the 
cell cycle promotes chro-
mosome missegregation and tumor 
formation, say van Ree et al.
The mitotic E2 enzyme 
UbcH10 partners with the ana-
phase-promoting complex/cyclo-
some (APC/C) to ubiquitinate cell 
cycle regulators, targeting them 
for proteasomal destruction, and ensuring progression through 
mitosis. UbcH10 is overexpressed in a variety of human cancers, 
but whether it causes tumors or is simply up-regulated due to the 
increased number of proliferating cancer cells is unknown.
van Ree et al. generated mice expressing high levels of 
UbcH10 and found that they formed tumors in a broad range 
of tissues. Many of these tumors displayed aneuploidy—abnormal 
numbers of chromosomes resulting from errors in cell division. Live 
microscopy showed that cells expressing high amounts of UbcH10 
had problems segregating sister chromatids correctly, possibly 
because the cells contained extra numbers of centrosomes that might 
complicate formation of a normal mitotic spindle. UbcH10 over-
expression also reduced levels of the mitotic regulator cyclinB—
a substrate of the APC/C—though it remains to be seen if this 
contributes directly to centrosome amplifi  cation and aneuploidy.
The same research group recently demonstrated that chro-
mosome segregation defects drive tumorigenesis by promoting 
the loss of tumor suppressor genes like p53. Senior author Jan 
van Deursen now wants to investigate whether UbcH10 syner-
gizes with other factors to promote chromosome instability in 
human cancers.
van Ree, J.H., et al. 2010. J. Cell Biol. doi:10.1083/jcb.200906147.
A single chromosome lags 
behind the others in a dividing 
cell overexpressing UbcH10.
Synaptic vesicles are well connected
F
ernández-Busnadiego et 
al. use cryo-electron to-
mography to investigate the 
structure of the presynapse, reveal-
ing important functions for short 
protein tethers in organizing synap-
tic vesicles at the nerve terminal.
The technique allowed the 
researchers to capture accurate, 
three-dimensional views of the 
presynaptic cytoplasm, and quan-
tify the effects of different pharmacological treatments. Actin is 
thought to be involved in organizing synaptic vesicle release, 
but Fernández-Busnadiego et al. saw relatively few actin fi  laments 
in the nerve terminals. Instead, many short fi  laments of unknown 
composition linked vesicles to each other and to the active zone of 
the presynaptic plasma membrane, where vesicles are exocytosed.
Vesicles were clustered together through links that the 
researchers termed “connectors.” These connections were rearranged 
when the synapses were strongly stimulated or treated with the phos-
phatase inhibitor okadaic acid. The researchers think the connectors 
regulate vesicle mobility and release in resting and active synapses.
In conventional electron microscopy studies, vesicles were 
proposed to stably contact the plasma membrane, but the team 
only saw direct contact when the vesicles were being exocytosed. 
Instead, vesicles near the active zone were docked by links that 
the authors named “tethers.” The tethers existed in long and short 
versions, the latter of which were absent in samples treated with 
tetanus toxin, indicating that they consist of SNARE proteins 
involved in membrane fusion. Vesicles with longer tethers were 
retained after mild synaptic stimulation, suggesting that they are 
at an early stage of docking and haven’t yet formed a readily 
releasable pool of SNARE-tethered vesicles.
Author Vladan Lučić now plans to examine more specifi  c 
drug treatments and the effects of genetic mutants on synaptic 
vesicle organization.
Fernández-Busnadiego, R., et al. 2010. J. Cell Biol. doi:10.1083/
jcb.200908082.
Short protein filaments link 
synaptic vesicles to each other 
(black arrow) and to the plasma 
membrane (white arrow).
ate in response to muscle injury, say Zhang et al.